公司资料
Summit Therapeutics 股价、新闻与催化剂
- 股票代码:
- SMMT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom with U
股票表现
12.78 USD (-4.27%)
收盘价
最后更新: 2026年8月17日
11.5B USD
市值
股价为何变动
As of Aug 17, 2026, SMMT closed down 4.27% at $12.78. No new same-company headline was identified in the current news window.
公司概览
业务概览
Summit Therapeutics is a biopharmaceutical company centered on oncology and the commercial potential of its lead cancer programs. The company has become a market focus because of its high-profile clinical and strategic story.
所在地与行业分类
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ, Summit sits in oncology biotechnology.
商业模式特征
Its model is driven by clinical data, partnering, and the possibility of turning a focused oncology program into a major value driver.
生物医药行业定位
Summit is a high-beta oncology name where data and strategic developments can quickly dominate the valuation.
未来催化剂
- Summit Therapeutics's catalysts are ivonescimab development and the next oncology readouts that could keep the PD-1 / VEGF story moving. The company matters most when the clinical data stay ahead of the hype.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。